Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Desquamative interstitial pneumonia: a systematic review of its features and outcomes.
Hellemons ME, Moor CC, von der Thüsen J, Rossius M, Odink A, Thorgersen LH, Verschakelen J, Wuyts W, Wijsenbeek MS, Bendstrup E. Hellemons ME, et al. Among authors: bendstrup e. Eur Respir Rev. 2020 Jun 23;29(156):190181. doi: 10.1183/16000617.0181-2019. Print 2020 Jun 30. Eur Respir Rev. 2020. PMID: 32581140 Free PMC article.
A cohort study of interstitial lung diseases in central Denmark.
Hyldgaard C, Hilberg O, Muller A, Bendstrup E. Hyldgaard C, et al. Among authors: bendstrup e. Respir Med. 2014 May;108(5):793-9. doi: 10.1016/j.rmed.2013.09.002. Epub 2013 Sep 20. Respir Med. 2014. PMID: 24636811 Free article.
Challenges in the classification of fibrotic ILD.
Bendstrup E, Maher TM, Manali ED, Wijsenbeek M. Bendstrup E, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:4-9. Sarcoidosis Vasc Diffuse Lung Dis. 2015. PMID: 26237436 Review.
Rituximab-induced interstitial lung disease: five case reports.
Naqibullah M, Shaker SB, Bach KS, Bendstrup E. Naqibullah M, et al. Among authors: bendstrup e. Eur Clin Respir J. 2015 May 21;2. doi: 10.3402/ecrj.v2.27178. eCollection 2015. Eur Clin Respir J. 2015. PMID: 26557260 Free PMC article.
Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Behr J, Bendstrup E, Crestani B, Günther A, Olschewski H, Sköld CM, Wells A, Wuyts W, Koschel D, Kreuter M, Wallaert B, Lin CY, Beck J, Albera C. Behr J, et al. Among authors: bendstrup e. Lancet Respir Med. 2016 Jun;4(6):445-53. doi: 10.1016/S2213-2600(16)30044-3. Epub 2016 May 5. Lancet Respir Med. 2016. PMID: 27161257 Clinical Trial.
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
Johannson KA, Strâmbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M; Erice ILD Working Group. Johannson KA, et al. Lancet Respir Med. 2017 Jul;5(7):591-598. doi: 10.1016/S2213-2600(17)30219-9. Lancet Respir Med. 2017. PMID: 28664861 Review.
233 results